636 related articles for article (PubMed ID: 26480048)
21. Participation and health care provision of statutory skin cancer screening in Germany - a secondary data analysis.
Anastasiadou Z; Schäfer I; Siebert J; Günther W; Reusch M; Augustin M
J Eur Acad Dermatol Venereol; 2016 Mar; 30(3):424-7. PubMed ID: 26856813
[TBL] [Abstract][Full Text] [Related]
22. The incidence and mortality of cutaneous melanoma in Southern Germany: trends by anatomic site and pathologic characteristics, 1976 to 2003.
Lasithiotakis KG; Leiter U; Gorkievicz R; Eigentler T; Breuninger H; Metzler G; Strobel W; Garbe C
Cancer; 2006 Sep; 107(6):1331-9. PubMed ID: 16909413
[TBL] [Abstract][Full Text] [Related]
23. Opportunistic screening strategy for cutaneous melanoma does not change the incidence of nodular and thick lesions nor reduce mortality: a population-based descriptive study in the European region with the highest incidence.
Bordoni A; Leoni-Parvex S; Peverelli S; Mazzola P; Mazzucchelli L; Spitale A
Melanoma Res; 2013 Oct; 23(5):402-7. PubMed ID: 23839077
[TBL] [Abstract][Full Text] [Related]
24. Target: melanoma: skin cancer screenings hold promise to reduce mortality rates, but usage of widespread screening lags.
Printz C
Cancer; 2013 Jul; 119(13):2359-60. PubMed ID: 23775430
[No Abstract] [Full Text] [Related]
25. A nationwide population-based skin cancer screening in Germany: proceedings of the first meeting of the International Task Force on Skin Cancer Screening and Prevention (September 24 and 25, 2009).
Geller AC; Greinert R; Sinclair C; Weinstock MA; Aitken J; Boniol M; Capellaro M; Doré JF; Elwood M; Fletcher SW; Gallagher R; Gandini S; Halpern AC; Katalinic A; Lucas R; Marghoob AA; Nolte S; Schüz J; Tucker MA; Volkmer B; Breitbart E
Cancer Epidemiol; 2010 Jun; 34(3):355-8. PubMed ID: 20381443
[TBL] [Abstract][Full Text] [Related]
26. Recent trends in incidence and mortality of oral and pharyngeal cancer in Schleswig-Holstein in Northern Germany.
Hertrampf K; Wiltfang J; Katalinic A; Timm O; Wenz HJ
Community Dent Health; 2012 Dec; 29(4):268-73. PubMed ID: 23488207
[TBL] [Abstract][Full Text] [Related]
27. The effectiveness of a population-based skin cancer screening program: evidence from Germany.
Kaiser M; Schiller J; Schreckenberger C
Eur J Health Econ; 2018 Apr; 19(3):355-367. PubMed ID: 28353004
[TBL] [Abstract][Full Text] [Related]
28. Melanoma screening: A plan for improving early detection.
Shellenberger R; Nabhan M; Kakaraparthi S
Ann Med; 2016; 48(3):142-8. PubMed ID: 26911192
[TBL] [Abstract][Full Text] [Related]
29. Variation in incidence of breast, lung and cervical cancer and malignant melanoma of skin by socioeconomic group in England.
Shack L; Jordan C; Thomson CS; Mak V; Møller H;
BMC Cancer; 2008 Sep; 8():271. PubMed ID: 18822122
[TBL] [Abstract][Full Text] [Related]
30. Effects of the German skin cancer screening programme on melanoma incidence and indicators of disease severity.
Trautmann F; Meier F; Seidler A; Schmitt J
Br J Dermatol; 2016 Nov; 175(5):912-919. PubMed ID: 27203791
[TBL] [Abstract][Full Text] [Related]
31. [Breast cancer mortality in women in the Schleswig-Holstein district 1981 to 1995].
Heitmann C; Bauer A; Hoffmann W; Kruse H
Gesundheitswesen; 2001 Jun; 63(6):383-91. PubMed ID: 11467221
[TBL] [Abstract][Full Text] [Related]
32. Screening for Skin Cancer in Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
Wernli KJ; Henrikson NB; Morrison CC; Nguyen M; Pocobelli G; Blasi PR
JAMA; 2016 Jul; 316(4):436-47. PubMed ID: 27458949
[TBL] [Abstract][Full Text] [Related]
33. Non-melanoma skin cancer incidence and impact of skin cancer screening on incidence.
Eisemann N; Waldmann A; Geller AC; Weinstock MA; Volkmer B; Greinert R; Breitbart EW; Katalinic A
J Invest Dermatol; 2014 Jan; 134(1):43-50. PubMed ID: 23877569
[TBL] [Abstract][Full Text] [Related]
34. Association between risk factors and detection of cutaneous melanoma in the setting of a population-based skin cancer screening.
Hübner J; Waldmann A; Eisemann N; Noftz M; Geller AC; Weinstock MA; Volkmer B; Greinert R; Breitbart EW; Katalinic A
Eur J Cancer Prev; 2018 Nov; 27(6):563-569. PubMed ID: 28692584
[TBL] [Abstract][Full Text] [Related]
35. Malignant melanoma and nonmelanoma skin cancers in Northrhine-Westphalia, Germany: a patient- vs. diagnosis-based incidence approach.
Stang A; Ziegler S; Büchner U; Ziegler B; Jöckel KH; Ziegler V
Int J Dermatol; 2007 Jun; 46(6):564-70. PubMed ID: 17550552
[TBL] [Abstract][Full Text] [Related]
36. Trends in melanoma in the elderly in Denmark, 1980-2012.
Hoejberg L; Gad D; Gyldenkerne N; Bastholt L;
Acta Oncol; 2016; 55 Suppl 1():52-8. PubMed ID: 26785326
[TBL] [Abstract][Full Text] [Related]
37. Screening program reduced melanoma mortality at the Lawrence Livermore National Laboratory, 1984 to 1996.
Schneider JS; Moore DH; Mendelsohn ML
J Am Acad Dermatol; 2008 May; 58(5):741-9. PubMed ID: 18068264
[TBL] [Abstract][Full Text] [Related]
38. Nationwide hospitalization costs of skin melanoma and non-melanoma skin cancer in Germany.
Stang A; Stausberg J; Boedeker W; Kerek-Bodden H; Jöckel KH
J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):65-72. PubMed ID: 18181975
[TBL] [Abstract][Full Text] [Related]
39. Interstate differences in incidence and mortality from melanoma. A re-examination of the latitudinal gradient.
Jones ME; Shugg D; Dwyer T; Young B; Bonett A
Med J Aust; 1992 Sep; 157(6):373-8. PubMed ID: 1447984
[TBL] [Abstract][Full Text] [Related]
40. Skin cancer mortality in Germany before and after the post-communist transition.
Stang A; Lampert T; Uhlemann T; Trocchi P
Int J Dermatol; 2009 Apr; 48(4):363-70. PubMed ID: 19335420
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
